New York State Common Retirement Fund Phathom Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 10,770 shares of PHAT stock, worth $80,236. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,770
Previous 10,770
-0.0%
Holding current value
$80,236
Previous $111,000
75.68%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PHAT
# of Institutions
144Shares Held
73.6MCall Options Held
42.3KPut Options Held
45.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$75.3 Million9.84% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$55.6 Million28.04% of portfolio
-
Jennison Associates LLC5.87MShares$43.7 Million0.07% of portfolio
-
Invesco Ltd. Atlanta, GA4.1MShares$30.5 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$26.1 Million9.52% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $292M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...